NM_198129.4:c.9211-21C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_198129.4(LAMA3):​c.9211-21C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.612 in 1,607,248 control chromosomes in the GnomAD database, including 317,497 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.51 ( 22805 hom., cov: 30)
Exomes 𝑓: 0.62 ( 294692 hom. )

Consequence

LAMA3
NM_198129.4 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -2.09

Publications

15 publications found
Variant links:
Genes affected
LAMA3 (HGNC:6483): (laminin subunit alpha 3) The protein encoded by this gene belongs to the laminin family of secreted molecules. Laminins are heterotrimeric molecules that consist of alpha, beta, and gamma subunits that assemble through a coiled-coil domain. Laminins are essential for formation and function of the basement membrane and have additional functions in regulating cell migration and mechanical signal transduction. This gene encodes an alpha subunit and is responsive to several epithelial-mesenchymal regulators including keratinocyte growth factor, epidermal growth factor and insulin-like growth factor. Mutations in this gene have been identified as the cause of Herlitz type junctional epidermolysis bullosa and laryngoonychocutaneous syndrome. Alternative splicing and alternative promoter usage result in multiple transcript variants. [provided by RefSeq, Dec 2014]
LAMA3 Gene-Disease associations (from GenCC):
  • junctional epidermolysis bullosa
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • laryngo-onycho-cutaneous syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • junctional epidermolysis bullosa Herlitz type
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • junctional epidermolysis bullosa, non-Herlitz type
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • generalized junctional epidermolysis bullosa non-Herlitz type
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 18-23946123-C-T is Benign according to our data. Variant chr18-23946123-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 255579.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.668 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_198129.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LAMA3
NM_198129.4
MANE Select
c.9211-21C>T
intron
N/ANP_937762.2Q16787-2
LAMA3
NM_000227.6
MANE Plus Clinical
c.4384-21C>T
intron
N/ANP_000218.3
LAMA3
NM_001127717.4
c.9043-21C>T
intron
N/ANP_001121189.2A0A0A0MSA0

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LAMA3
ENST00000313654.14
TSL:1 MANE Select
c.9211-21C>T
intron
N/AENSP00000324532.8Q16787-2
LAMA3
ENST00000269217.11
TSL:1 MANE Plus Clinical
c.4384-21C>T
intron
N/AENSP00000269217.5Q16787-1
LAMA3
ENST00000399516.7
TSL:1
c.9043-21C>T
intron
N/AENSP00000382432.2Q16787-3

Frequencies

GnomAD3 genomes
AF:
0.514
AC:
78049
AN:
151742
Hom.:
22806
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.268
Gnomad AMI
AF:
0.707
Gnomad AMR
AF:
0.484
Gnomad ASJ
AF:
0.704
Gnomad EAS
AF:
0.162
Gnomad SAS
AF:
0.410
Gnomad FIN
AF:
0.627
Gnomad MID
AF:
0.596
Gnomad NFE
AF:
0.674
Gnomad OTH
AF:
0.551
GnomAD2 exomes
AF:
0.534
AC:
134214
AN:
251384
AF XY:
0.546
show subpopulations
Gnomad AFR exome
AF:
0.257
Gnomad AMR exome
AF:
0.373
Gnomad ASJ exome
AF:
0.700
Gnomad EAS exome
AF:
0.165
Gnomad FIN exome
AF:
0.625
Gnomad NFE exome
AF:
0.675
Gnomad OTH exome
AF:
0.604
GnomAD4 exome
AF:
0.622
AC:
905897
AN:
1455388
Hom.:
294692
Cov.:
33
AF XY:
0.620
AC XY:
449067
AN XY:
724342
show subpopulations
African (AFR)
AF:
0.251
AC:
8398
AN:
33392
American (AMR)
AF:
0.388
AC:
17331
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.699
AC:
18229
AN:
26082
East Asian (EAS)
AF:
0.138
AC:
5479
AN:
39676
South Asian (SAS)
AF:
0.426
AC:
36664
AN:
86128
European-Finnish (FIN)
AF:
0.633
AC:
33835
AN:
53410
Middle Eastern (MID)
AF:
0.604
AC:
3471
AN:
5744
European-Non Finnish (NFE)
AF:
0.675
AC:
746532
AN:
1106078
Other (OTH)
AF:
0.598
AC:
35958
AN:
60164
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
13854
27708
41562
55416
69270
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18694
37388
56082
74776
93470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.514
AC:
78061
AN:
151860
Hom.:
22805
Cov.:
30
AF XY:
0.506
AC XY:
37533
AN XY:
74238
show subpopulations
African (AFR)
AF:
0.268
AC:
11085
AN:
41382
American (AMR)
AF:
0.484
AC:
7380
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.704
AC:
2443
AN:
3468
East Asian (EAS)
AF:
0.162
AC:
839
AN:
5170
South Asian (SAS)
AF:
0.410
AC:
1968
AN:
4798
European-Finnish (FIN)
AF:
0.627
AC:
6601
AN:
10528
Middle Eastern (MID)
AF:
0.602
AC:
177
AN:
294
European-Non Finnish (NFE)
AF:
0.674
AC:
45777
AN:
67954
Other (OTH)
AF:
0.546
AC:
1152
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1635
3270
4905
6540
8175
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
664
1328
1992
2656
3320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.616
Hom.:
82514
Bravo
AF:
0.493
Asia WGS
AF:
0.285
AC:
991
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
Junctional epidermolysis bullosa gravis of Herlitz (1)
-
-
1
Junctional epidermolysis bullosa, non-Herlitz type (1)
-
-
1
Laryngo-onycho-cutaneous syndrome (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.057
DANN
Benign
0.53
PhyloP100
-2.1
PromoterAI
-0.0085
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2288592; hg19: chr18-21526087; COSMIC: COSV52531938; COSMIC: COSV52531938; API